Clinical Trials on SLC35A2-CDG - Solute Carrier Family 35 Member A2 Congenital Disorder of Glycosylation in Korea, Democratic People's Republic of
Total 0 results
Nothing found
Sponsors and Collaborators
- Julie Lefevere
- Azumio Inc.
- National Institute of Diabetes and Endocrinology, Egypt
- Stanford's Innovative Medicines Accelerator
- Daqiao Community Health Service Center of Yangpu District
- Montera Health Texas LLC
- University Mental Health Research Institute, Athens, Greece
- National Institute of Drug Abuse
- Health Factors Inc
- Ondine Biomedical Inc.
- Michael Scharl
- Dr. Siyami Ersek Thoracic and Cardiovascular Surgery Training and Research Hospital
- Ancon Technologies Ltd
- Robert Pendleton
- Rotem Petranker
- Genesis Foundation
- Spokane Regional Health District
- AVAX Technologies
- Manresana de Micobacteriologia, SL
- Prostate Cure Foundation
- View Full List
Medical Conditions
- Connective Active Program
- Conditions for Which There is a Documented Medical Necessity to Receive Treatment With Rotigotine
- Acute Myocardial Infarction With ST Segment Elevation
- Glanzmann's Thrombasthenia
- Isolation of Enterococci From Samples
- Simulation Training, Laparoscopy
- Vital Signs
- Universal Adhesive
- Age of Probands 18 - 55 Years
- Thymoglobulin Dose
- Limb-Girdle Muscular Dystrophy, Type 2I (FKRP-deficiency)
- Unwanted Abdomen Fat
- Desmoid
- Skin Burn Multiple
- Transformed Chronic Lymphocytic Leukemia to Diffuse Large B-Cell Lymphoma
- Peripheral Artery Calcification
- Immunochromatographic
- Convalescent Plasma for COVID 19
- Pain Due to Childhood Vaccination
- Ischemic Stroke, Cryptogenic
- View Full List
Drug Interventions
- Administration of etoricoxib
- DKN-01
- Nab-paclitaxel
- Megestrol Acetate 160 MG
- Ciclesonide
- JNJ 10229570-AAA 3.6% cream
- Colchicine group (experimental arm)
- Zydena (Udenafil) 100mg + Donepezil 5mg or 10mg
- Human menopausal gonadotropin
- PD-0332991
- Uprifosbuvir
- Glycopyrrolate
- Treament C
- Formulation N3
- Golcadomide
- Single dose of vepdegestrant as tablet formulation (Treatment A)
- Mild sedation and analgesia
- G-CSF
- Bevacizumab
- GM-CSF
- View Full List
CROs by country
- Contract Research Organizations in Algeria
- Contract Research Organizations in Azerbaijan
- Contract Research Organizations in Bangladesh
- Contract Research Organizations in Congo
- Contract Research Organizations in Congo, DR of
- Contract Research Organizations in Czech Republic
- Contract Research Organizations in Japan
- Contract Research Organizations in Mauritius
- Contract Research Organizations in Norway
- Contract Research Organizations in Philippines
- Contract Research Organizations in Senegal
- Contract Research Organizations in Uganda
- Contract Research Organizations in Zambia
- CRO list by country